<p>Wound healing assays were performed on PNT1A, LNCaP, PC3 and DU145 cells in the absence or the presence of the TRPM8 inhibitors AMTB and JNJ41876666 (10 µM). A. Representative images of experiments performed in the presence of normal serum concentrations. In the absence of blocker, all cell lines efficiently restore the monolayer after 24 (LNCaP and DU145) or 48 h (PNT1A; at 24 h, no recovery was observed). The presence of blockers impairs healing in LNCaP, PC3 and DU145, but not in PNT1A cells. B. Similar effects were observed on all cell lines already 12 h after the scratch. C. Quantification of restored surface from three images like those in A, for 24 h in all cell lines, except PNT1A (48 h) in the presence of JNJ41876666 (black) and...
TRPM8 has recently emerged as a druggable target in prostate cancer (PC) and TRPM8 modulators have b...
In the fight against prostate cancer (PCa), TRPM8 is one of the most promising clinical targets. Ind...
TRPM8 has recently emerged as a druggable target in prostate cancer (PC) and TRPM8 modulators have b...
Overexpression of the cation-permeable channel TRPM8 in prostate cancers might represent a novel opp...
<p>Histograms show changes in the proliferative fraction in the presence of channel blockers as dete...
Transient receptor potential melastatin-8 (TRPM8) represents an emerging target in prostate cancer, ...
International audienceAlthough the transient receptor potential melastatin 8 (TRPM8) cold receptor i...
Transient receptor potential melastatin-8 (TRPM8) represents an emerging target in prostate cancer, ...
TRPM8 has recently emerged as a druggable target in prostate cancer (PC) and TRPM8 modulators have b...
In the fight against prostate cancer (PCa), TRPM8 is one of the most promising clinical targets. Ind...
TRPM8 has recently emerged as a druggable target in prostate cancer (PC) and TRPM8 modulators have b...
Overexpression of the cation-permeable channel TRPM8 in prostate cancers might represent a novel opp...
<p>Histograms show changes in the proliferative fraction in the presence of channel blockers as dete...
Transient receptor potential melastatin-8 (TRPM8) represents an emerging target in prostate cancer, ...
International audienceAlthough the transient receptor potential melastatin 8 (TRPM8) cold receptor i...
Transient receptor potential melastatin-8 (TRPM8) represents an emerging target in prostate cancer, ...
TRPM8 has recently emerged as a druggable target in prostate cancer (PC) and TRPM8 modulators have b...
In the fight against prostate cancer (PCa), TRPM8 is one of the most promising clinical targets. Ind...
TRPM8 has recently emerged as a druggable target in prostate cancer (PC) and TRPM8 modulators have b...